Properties of nanomaterials determine their disposal by liver cells. This project aims to understand how the liver handles and is affected by nanomaterials in the body. Nanomaterials are widely used in industrial, environmental, consumer and drug products, but how they affect human health is poorly understood. This project will characterise the spatiotemporal distribution of a set of nanomaterials with defined attributes in naïve and modified livers using chemistry, imaging and biological method ....Properties of nanomaterials determine their disposal by liver cells. This project aims to understand how the liver handles and is affected by nanomaterials in the body. Nanomaterials are widely used in industrial, environmental, consumer and drug products, but how they affect human health is poorly understood. This project will characterise the spatiotemporal distribution of a set of nanomaterials with defined attributes in naïve and modified livers using chemistry, imaging and biological methods. This work is expected to determine how nanomaterials’ attributes direct pathways for liver cell disposal and describe nanomaterial–liver interactions at the cellular level, information crucial in enabling safer nanomaterials for use in products such as drug formulations, sunscreens and cosmetics.Read moreRead less
Early Career Industry Fellowships - Grant ID: IE230100564
Funder
Australian Research Council
Funding Amount
$353,258.00
Summary
On-Site, Reponsive and Less Invasive Drug Testing In Corrective Services. This project aims to develop a new drug screening system using nanomaterials interfaced with advanced mass spectrometry to improve testing speed, cost, and accuracy, and minimise the distress associated with current drug testing programs within corrective services. Currently, testing programs are costly, with confirmation taking multiple weeks, preventing appropriate responses to drug use and support service recommendation ....On-Site, Reponsive and Less Invasive Drug Testing In Corrective Services. This project aims to develop a new drug screening system using nanomaterials interfaced with advanced mass spectrometry to improve testing speed, cost, and accuracy, and minimise the distress associated with current drug testing programs within corrective services. Currently, testing programs are costly, with confirmation taking multiple weeks, preventing appropriate responses to drug use and support service recommendations. Additionally, vulnerable people in custody or on corrective orders find conventional urine testing distressing, especially when previously exposed to sexual violence. New accurate, rapid saliva testing on-site will revolutionise drug monitoring and provide an Australian designed solution for correctional jurisdictions. Read moreRead less